Introduction
Adenovirus is one of the most important pathogens causing lower respiratory tract infections in children [
1], and complications of severe adenovirus pneumonia, such as obliterative bronchiolitis (OB) and interstitial fibrosis, severely compromise the normal development of the children and even threaten their safety [
2]. The prognosis for children with severe adenovirus pneumonia is minimally favorable, with a mortality rate of up to 11% in the acute phase of the disease and a 56.3% incidence of surviving sequelae [
3]. OB is a major sequela of severe adenovirus pneumonia and is characterized by chronic cough, persistent wheezing, shortness of breath or dyspnea, resulting in relatively weak exercise tolerance in affected children [
4]. Currently, specific clinical treatment for OB after adenovirus infection in children is not yet available [
5]. However, the clinical features of OB following adenovirus infection have been marginally reported. The present study retrospectively analyzed the medical data of 62 children with adenovirus pneumonia treated in our hospital between February 2020 and November 2021 to explore the inflammatory markers for the development of OB after adenovirus infection in children, so as to provide a reference for clinical interventions.
1. Materials and Methods
Ethical statement
The protocol was approved by the ethics committee of Medical Record Room of Shiyan MCH hospital. Informed consent was obtained from all study participants. All the methods were carried out in accordance with the Declaration of Helsinki.
1.1. Participants and Grouping
In this retrospective study, the medical data of 62 children with adenovirus pneumonia treated in our hospital between February 2020 and November 2021 were collected and assigned to an OB group (n = 30) or non-OB group (n = 32) according to the presence of OB.
Inclusion criteria: (1) children were diagnosed with adenovirus pneumonia by clinically relevant test results; (2) all eligible children were treated in our hospital; (3) children with complete clinical data.
Exclusion criteria: children who died during the experiment were excluded.
1.2. Disease Diagnostic Criteria
Clinical diagnostic criteria for OB: (1) the child has an acute lower respiratory tract infection or post-lung injury condition [
6]; (2) the child presents with symptoms such as persistent wheezing or shortness of breath, and significant wheezing and wet rales can be heard in both lungs of the child on auscultation using a stethoscope [
7]; (3) the child's chest CT shows significant mosaic perfusion signs as well as bronchodilation [
8].
1.3. Outcome Measures
Clinical data and relevant laboratory data were collected from the eligible children.
Clinical data included gender, age, prematurity, underlying disease, mixed bacterial infection, days of hospitalization, type of adenovirus infection, ventilator use, and length of ventilator use.
Laboratory-related index levels included serum immunoglobulin E (IgE), interleukin-6 (IL-6), partial arterial pressure of oxygen (PaO2), serum ferritin, D-dimer, lactate dehydrogenase (LDH), and absolute lymphocyte values.
1.4. Statistical Analysis
SPSS 20.0 was used for the statistical analyses, the median and interquartile spacing were used to express the level of each index, and the Mann-Whitney U test in the nonparametric test was adopted. Fisher's exact test was used for the selection of the columns. The influencing factors of severe adenovirus pneumonia complicated by OB were analyzed by Lasso logistic regression. Statistical significance of the comparison was indicated by P < 0.05.
2. Results
2.1. Patient Characteristics
The differences in age, gender, underlying medical conditions, and mixed bacterial infections between the two groups of children did not come up to the statistical standard (P > 0.05). The OB group showed a higher proportion of HAdV-7-type infections and ventilator use and a longer duration of ventilator use and ICU stay than the non-OB group (P < 0.05). (
Table 1)
2.2. Laboratory-Related Index Levels
Children with OB were associated with higher serum ferritin levels versus those without (P < 0.05). There were no significant differences in the IgE, IL-6, PaO2, D-dimer, LDH, and lymphocyte absolute values between the two groups of children (P > 0.05). (
Table 2)
2.3. Logistic Regression Analysis
Logistic multifactorial regression analysis revealed that the length of ventilator use and serum ferritin level were inflammatory markers for the development of OB in children with adenovirus pneumonia. (
Table 3)
3. Discussion
The occurrence of OB in children is usually associated with lower respiratory tract infections, of which adenovirus infections are the most common [
9]. Clinical research has reported that severe adenovirus pneumonia is an important factor in the development of OB in children [
10]. A study by Li [
11] et al. revealed that prevention of OB after adenovirus pneumonia infection in children is essential for the subsequent quality of life of the children. Fang [
12] et al. followed 62 children with adenovirus pneumonia for up to 48 months and found that the incidence of OB was about 48% and that the development of OB was associated with mechanical ventilation. However, the results of their study showed that 46% of children with OB experienced nosocomial infections, but the comparison of mode and duration of mechanical ventilation was absent [
13]. In the present study, OB children required a longer use of ventilators than non-OB children. The presence of a certain amount of positive end-expiratory pressure in the ventilation mode undertaken for the children may cause compressional injuries to the lungs, which indicates the significance of the regulation of positive end-expiratory pressure conditions in children with adenoviral pneumonia during ventilatory treatment [
14]. The results of the current study also found a higher proportion of HAdV-7 infection in OB children than in non-OB children, which may be related to the stronger activation of macrophages by HAdV-7 than by HAdV-3, resulting in increased inflammation within the lungs of the children. Hence, timely viral typing of adenovirus pneumonia and prompt monitoring of TNF-α, 1L-6, IL-8, and IL-10 levels contribute positively to patient prognosis [
15], and early clinical pharmacological interventions to reduce the inflammatory response of the children facilitate the prevention of complications and sequelae after infection in children. Wang [
16] et al. showed that hypoxemia is one of the risk factors for sequelae in children with infection, but the PaO2 levels of the two groups of children in the current study were not statistically significant. This discrepancy may be attributed to the different grouping criteria of the two studies, as the included children with respiratory adenovirus infection in the study by Wang et al included upper respiratory tract infection, mild pneumonia, and severe pneumonia, while the subjects of the present study were all with severe pneumonia. Ma [
17] et al. found that early mechanical ventilation in children with adenovirus-infected pneumonia contributed to lowering the incidence of complications and sequelae.
Children with adenovirus pneumonia are often accompanied by diverse mixed infections, with 86.4% of mixed infections occurring in the current study. Li [
18] et al. summarized the clinical characteristics of 153 children with adenovirus pneumonia and found a significantly higher proportion of acute mixed infections in the OB group than in the non-B0 group, but in the current study, there was no statistically significant difference in the comparison of the above indicators between the two groups, which may be attributed to the small sample size herein; however, it also suggests that the relationship between mixed infection and OB after adenovirus infection has a positive impact on the prevention of OB [
19]. Several studies have reported higher LDH levels in children with OB than in those without, while in the present study, the difference in the LDH levels between the two groups did not come up to the statistical standard, and the LDH levels in both groups were higher than the normal reference value. The inconsistency of outcomes may be attributable to the different inclusion criteria as well as the mixed infections. Serum IgE levels in children are an important marker of inflammation. In the current study, both groups of children showed slightly elevated IgE levels, and a positive correlation between serum IgE levels and the age of the children was found at follow-up, with the older age of the children indicating poorer quality of life at follow-up [
20]. Furthermore, serum ferritin levels were significantly higher in the OB group than in the non-OB group. The pathological changes of OB after infection are similar to those of interstitial lung disease, and the increase in serum ferritin levels in children induces the formation of the fibrous nature of the lungs. Serum ferritin levels also present a predictive value for the magnitude of the inflammatory response in the lungs of the children. In addition, the results after multifactorial analysis demonstrated that the occurrence of OB after severe adenovirus pneumonia infection in children was associated with the length of ventilator use and the level of serum ferritin before treatment.
The limitations of this study are the small sample size, short follow-up, single clinical data center, and the absence of cytokine and flow cytology tests [
21]. Therefore, future studies will be conducted to refine the above-mentioned issues to further validate and discuss the results of this study.
4. Conclusion
The length of ventilator use and serum ferritin levels are inflammatory markers for the development of OB after adenovirus infection in children, and timely measurement of the above indicators in children is instrumental in predicting the prognosis of children.
Author Contributions
The authors declare that this work was done by the authors named in this article and all liabilities pertaining to claims relating to the content of this article will be borne by them. All authors reviewed the manuscript. All authors have read and approved the manuscript.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Ethics approval and consent to participate
This study has been approved by Hospital ethics committee and Patients and their families were informed of the research content and voluntarily signed the informed consent consent. All the methods were carried out in accordance with the Declaration of Helsinki.
Consent for publication
Not applicable.
Availability of data and materials
All data generated or analysed during this study are included in this published article.
Acknowledgements
Not applicable.
Conflict of Interest
All authors declarted that they have no conflict of interest.
References
- Lee, E.; Lee, Y.Y. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance. Respir Med 2020, 175, 106209. [Google Scholar] [CrossRef]
- Colom, A.J.; et al. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 2006, 61, 503–6. [Google Scholar] [CrossRef]
- Colom, A.J.; et al. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up. Thorax 2015, 70, 169–74. [Google Scholar]
- Gupta, P.; et al. Prolonged mechanical support in children with severe adenoviral infections: a case series and review of the literature. J Intensive Care Med 2011, 26, 267–72. [Google Scholar] [CrossRef]
- Aguerre, V.; et al. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol 2010, 45, 1180–5. [Google Scholar] [CrossRef]
- Li, Y.N.; et al. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr 2014, 14, 238. [Google Scholar] [CrossRef] [PubMed]
- Giubergia, V.; et al. Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children. Respirology 2015, 20, 982–6. [Google Scholar] [CrossRef]
- Murtagh, P.; et al. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol 2009, 44, 450–6. [Google Scholar] [CrossRef] [PubMed]
- Smith, K.J.; Fan, L.L. Insights into post-infectious bronchiolitis obliterans in children. Thorax 2006, 61, 462–3. [Google Scholar] [CrossRef] [PubMed]
- Mallol, J.; Aguirre, V.; Espinosa, V. Increased oxidative stress in children with post infectious Bronchiolitis Obliterans. Allergol Immunopathol (Madr) 2011, 39, 253–8. [Google Scholar] [CrossRef] [PubMed]
- Wu, P.Q.; et al. Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children. Springerplus 2016, 5, 1622. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; et al. Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia. PLoS One 2018, 13, e0205795. [Google Scholar] [CrossRef] [PubMed]
- Foong Ng, K.; et al. Epidemiology of adenovirus respiratory infections among hospitalized children in Seremban, Malaysia. Trans R Soc Trop Med Hyg 2015, 109, 433–9. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Tan, X.; Li, Q. The difference in clinical features and prognosis of severe adenoviral pneumonia in children of different ages. J Med Virol 2022, 94, 3303–3311. [Google Scholar] [CrossRef]
- Colom, A.J.; Teper, A.M. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol 2009, 44, 1065–9. [Google Scholar] [CrossRef]
- Wang, X.; et al. Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment. Exp Ther Med 2015, 9, 2379–2383. [Google Scholar] [CrossRef]
- Zhang, H.Y.; et al. [Clinical features of children with severe adenovirus pneumonia and hemophagocytic syndrome: an analysis of 30 cases]. Zhongguo Dang Dai Er Ke Za Zhi 2020, 22, 744–748. [Google Scholar]
- Ions, R.; et al. Case presentation: persistent adenovirus B3 infections associated with bronchiolitis obliterans treated with cidofovir in a child with mosaic tetrasomy 9p. BMC Infect Dis 2018, 18, 529. [Google Scholar] [CrossRef]
- Byun, S.Y.; et al. Bronchiolitis obliterans caused by CMV in a previously healthy Asian infant. Turk J Pediatr 2014, 56, 316–9. [Google Scholar]
- Colom, A.; et al. Authors' response: Long-term lung function in postinfectious bronchiolitis obliterans. Thorax 2015, 70, 793. [Google Scholar] [CrossRef]
- Castro-Rodriguez, J.A. , et al. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol 2006, 41, 947–53. [Google Scholar] [CrossRef] [PubMed]
Table 1.
Patient characteristics [n(%), IQR].
Table 1.
Patient characteristics [n(%), IQR].
|
Non-OB (n=32) |
OB (n=30) |
Z/x² |
P-value |
Age (month) |
20.0(15.1-46.0) |
22.0(10.3-30.5) |
-0.898 |
0.369 |
Sex (Female) |
6(26.1) |
5(24.9) |
0.554 |
0.457 |
Preterm delivery |
1 |
3 |
0.462 |
0.523 |
Underlying disease |
4(17.4) |
4(18.2) |
|
1.000 |
Mixed bacterial infection |
18(78.3) |
19(86.4) |
|
0.699 |
Length of hospitalization (d) |
5.0(3.0-7.0) |
7.5(6.0-11.0) |
-2.821 |
0.005 |
Viral typing |
|
|
|
|
Untyped |
7(21.7) |
0(0.0) |
|
|
HAdV-3 |
14(43.5) |
11(36.4) |
6.682 |
0.030 |
HAdV-7 |
11(34.8) |
19(63.6) |
|
|
Ventilator use |
|
|
|
|
None |
17(52.2) |
3(9.1) |
|
|
Non-invasive ventilation |
10(30.4) |
18(59.1) |
9.744 |
0.008 |
Invasive ventilation |
5(17.4) |
9(31.8) |
|
|
Duration of ventilator use (h) |
72.5(0.0-113.5) |
159.0(111.5-202.5) |
-3.567 |
0.000 |
Table 2.
Laboratory-related index levels (IQR).
Table 2.
Laboratory-related index levels (IQR).
|
Non-OB (n=32) |
OB (n=30) |
Z/x² |
P-value |
IgE (KU/L) |
65.0(33.0-122.0) |
55.0(25.4-87.3) |
-0.534 |
0.594 |
IL-6 (pg/mL) |
55.0 (23.0-83.3) |
42.5(20.5-68.9) |
0.568 |
0.570 |
PaO2 (mm Hg) |
83.0(63.2-110.4) |
74.8(57.6-90.2) |
-1.408 |
0.159 |
Serum ferritin (ng/mL) |
611.5(260.0-989.8) |
885.0(684.0-1645.0) |
-2.680 |
0.007 |
D-dimer (ng/mL) |
2245.0(985.0-3478.0) |
2819.5(976.0-4 624.0) |
-0.500 |
0.617 |
LDH(IU/L) |
630.0(349.0-1425.0) |
638.0(392.8-1133.8) |
-0.182 |
0.856 |
Absolute value of lymphocytes (×109/L) |
2.2(1.7-2.7) |
1.9(1.3-2.8) |
0.466 |
0.642 |
Table 3.
Logistic regression analysis.
Table 3.
Logistic regression analysis.
Factors |
SE |
Wald X² |
P-value |
OR |
95%CI |
Duration of ventilator use |
0.027 |
4.598 |
0.032 |
0.943 |
0.894-0.995 |
Serum ferritin |
0.003 |
4.369 |
0.037 |
1.006 |
1.000-1.011 |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).